Effects of Rosiglitazone and Metformin on Metabolism in Type 2 Diabetes

NCT02526615 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

48

Enrollment

OTHER_GOV

Sponsor class

Conditions

Insulin Sensitivity
Type 2 Diabetes

Interventions

DRUG: Rosiglitazone
DRUG: Metformin
DRUG: Placebo

Sponsor

Turku University Hospital

Collaborators

[object Object]